Chief Executive Officer

Chief Financial Officer

GeneDx raises FY25 revenue view to $425M-$428M from $400M-$415M

GeneDx files automatic mixed securities shelf

GeneDx reports Q3 adjusted EPS 49c, consensus 42c

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Associate Director, Cash Posting & Correspondence

GeneDx is a company that delivers personalized and actionable health insights to inform diagnosis and improve drug discovery. The Associate Director, Cash Posting and Correspondence will oversee the accurate posting of payments and handling of payer correspondence, ensuring the integrity of financial data and driving process improvements within a high-volume genetic testing laboratory.

Sign up with Google

Sign in with Google